Intellia Therapeutics Inc (NTLA)

Nov 28, 2025

Pullback Watch: Will Intellia Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Weekly Recap & Intraday High Probability Alerts - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Can NTLA's In Vivo Pipeline Drive Long-Term Growth Amid Rivalry? - Zacks Investment Research

Nov 28, 2025

Nov 28, 2025

BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential? - sharewise.com

Nov 28, 2025

Nov 28, 2025

Will Intellia Therapeutics Inc. stock remain a Wall Street favorite2025 Geopolitical Influence & Accurate Intraday Trading Signals - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Operating cash flow per share of Intellia Therapeutics, Inc. – LSX:A2AG6H - TradingView

Nov 27, 2025

Nov 27, 2025

Is Intellia Therapeutics Inc 38I a good long term investmentDividend Yield Trends & These Picks Are Just One Breakout Away - earlytimes.in

Nov 27, 2025

Nov 26, 2025

5 Stocks with the Largest Fair Value Estimate Cuts After Q3 Earnings - Morningstar

Nov 26, 2025

Nov 25, 2025

Intellia Therapeutics Shares: A Crisis Crossroads - Ad-hoc-news.de

Nov 25, 2025

Nov 25, 2025

Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress - Insider Monkey

Nov 25, 2025

Nov 23, 2025

9 Oversold Biotech Stocks to Invest In - Insider Monkey

Nov 23, 2025

Nov 22, 2025

NTLA Stockholders Have Opportunity to Lead Intellia Therapeutics - The National Law Review

Nov 22, 2025

Nov 22, 2025

Intellia Therapeutics, Inc. Sued for Securities Law Violations – - The National Law Review

Nov 22, 2025

Nov 21, 2025

NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock? - Finviz

Nov 21, 2025

Nov 20, 2025

Intellia Therapeutics, Inc. Class Action: Levi & Korsinsky Remind - The National Law Review

Nov 20, 2025

Nov 20, 2025

Is Intellia Therapeutics Attractive After a 70.6% Drop and Latest Clinical Trial Update? - Yahoo Finance

Nov 20, 2025

Nov 20, 2025

Will Intellia Therapeutics Inc. (38I) stock benefit from mergersJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Will Intellia Therapeutics Inc. (38I) stock outperform value peersEntry Point & AI Forecasted Entry/Exit Points - newser.com

Nov 20, 2025

Nov 19, 2025

What technical models suggest about Intellia Therapeutics Inc.’s comebackWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

How Intellia Therapeutics Inc. stock reacts to oil pricesJuly 2025 Earnings & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Can Intellia Therapeutics Inc. stock deliver surprise earnings beatMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com

Nov 19, 2025

Nov 19, 2025

Can volume confirm reversal in Intellia Therapeutics Inc.2025 Price Targets & Long Hold Capital Preservation Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Will Intellia Therapeutics Inc. (38I) stock recover faster than industryJuly 2025 Action & Pattern Based Trade Signal System - newser.com

Nov 19, 2025

Nov 19, 2025

Intellia Therapeutics: A Worst-Case Risk Becomes A Tragic Reality (Downgrade) - Seeking Alpha

Nov 19, 2025

Nov 19, 2025

Why Intellia Therapeutics Inc. (38I) stock remains top ratedJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Intellia Therapeutics (NTLA): Exploring Valuation as Investors Digest Latest Quarterly Update - Sahm

Nov 19, 2025

Nov 19, 2025

Is Intellia Therapeutics Inc. still worth holding after the dipJuly 2025 Update & Community Supported Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Can Intellia Therapeutics Inc. stock deliver strong Q4 earnings2025 Earnings Impact & Daily Market Momentum Tracking - newser.com

Nov 19, 2025

Nov 18, 2025

Intellia Therapeutics Faces Weak Start with 10.21% Gap Down Amid Market Concerns - Markets Mojo

Nov 18, 2025

Nov 18, 2025

What data driven models say about Intellia Therapeutics Inc.’s futureFed Meeting & Daily Chart Pattern Signal Reports - newser.com

Nov 18, 2025

Nov 18, 2025

Intellia Therapeutics Stock (NTLA) Opinions on Clinical Trial Suspension - Quiver Quantitative

Nov 18, 2025

Nov 18, 2025

Evercore Downgrades Intellia (NTLA) Despite Strong ATTR Trial Data - Insider Monkey

Nov 18, 2025

Nov 18, 2025

9 Best Gene-Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Nov 18, 2025

Nov 17, 2025

Intellia Therapeutics Shares Plunge on Clinical Trial Safety Concerns - AD HOC NEWS

Nov 17, 2025